We are monitoring the impact of COVID-19 on MEA Cancer Biomarkers Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2151
Share on
Share on

Middle East & Africa Cancer Biomarkers Market Research Report – Segmented By Disease, Services, Application, Type, Profiling Technologies, Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2151
Pages: 145

MEA Cancer Biomarkers Market Size (2021 to 2026)

The size of the Cancer Biomarkers Market in the Middle East & Africa was worth USD 1.15 billion in 2021 and estimated to be growing at a CAGR of 11.652% to reach USD 2.00 billion by 2026.

Biomarkers are used in imaging technology to offer precise imaging of oncology tumors and other problems and also eradicate the possibility of radiation exposure during imaging through CT scans and MRI scans. In addition, biomarkers facilitate pharmaceutical companies to analyze and discover novel drugs as demand for valuable and efficient treatment doses increases.

The cancer biomarkers market is expected to witness lucrative growth over the forecast period owing to the rising prevalence of cancer, improper diet, increasing consumption of tobacco, lack of physical activities, and many sun & UV exposures. Furthermore, the growing geriatric population base, raising awareness regarding the usage of biomarkers at various stages of cancers, and rising demand for clinical diagnosis in the early stages of cancers are some factors that are expected to boost usage rates.

The high cost of diagnostic procedures is restraining market growth.

This research report on the MEA Cancer Biomarkers Market segmented and sub-segmented into the following categories:

By Disease: 

  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Other Cancers

By Services: 

  • Sample Preparation
  • Assay Development
  • Biomarkers Validation
  • Testing

By Application: 

  • Risk Assessment
  • Development of Molecular Diagnostics
  • Disease Diagnosis
  • Drug Discovery & Development
  • Drug Formulation

By Type: 

  • Protein Biomarkers
  • Genetic Biomarkers
  • Other Biomarkers

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

KEY MARKET PLAYERS:

Some of the prominent companies operating in the Middle East & Africa cancer biomarkers market profiled in this report are Abbott Laboratories, Agendia Bv, Biocurex Inc, Biomerieux S.A, Biomoda Inc., Astellas Pharma Us Inc., Correlogic Systems Inc., Beckman Coulter Inc., Becton, Dickinson and Company, Clarient Inc., Diadexus Inc., Ambrilia Biopharma, Affymetrix Inc and Aureon Laboratories Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Disease                        

                                5.1.1 Introduction           

                                5.1.2 Prostate Cancer    

                                5.1.3 Breast Cancer        

                                5.1.4 Lung Cancer            

                                5.1.5 Colorectal Cancer 

                                5.1.6 Cervical Cancer      

                                5.1.7 Other Cancers       

                                5.1.8  Y-o-Y Growth Analysis, By Disease               

                                5.1.9  Market Attractiveness Analysis, By Disease             

                                5.1.10  Market Share Analysis, By Disease            

                5.2 Services                       

                                5.2.1 Introduction           

                                5.2.2 Sample Preparation            

                                5.2.3 Assay development            

                                5.2.4 Biomarkers validation and testing 

                                5.2.5  Y-o-Y Growth Analysis, By Services              

                                5.2.6  Market Attractiveness Analysis, By Services            

                                5.2.7  Market Share Analysis, By Services             

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Risk Assessment   

                                5.3.3 Development of molecular diagnostics       

                                5.3.4 Disease diagnosis 

                                5.3.5 Drug discovery      

                                5.3.6 Development and Drug formulation            

                                5.3.7  Y-o-Y Growth Analysis, By Application        

                                5.3.8  Market Attractiveness Analysis, By Application      

                                5.3.9  Market Share Analysis, By Application       

                5.4 Type                              

                                5.4.1 Introduction           

                                5.4.2 Protein Biomarkers             

                                5.4.3 Genetic biomarkers            

                                5.4.4 genetic biomarkers             

                                5.4.7  Y-o-Y Growth Analysis, By Type    

                                5.4.8  Market Attractiveness Analysis, By Type  

                                5.4.9  Market Share Analysis, By Type    

                5.5 Profiling Technologies                            

                                5.5.1 Omics technologies             

                                                5.5.1.1 Genomics

                                                5.5.1.2 Proteomics

                                                5.5.1.3 Metabolomics

                                                5.5.1.4 Transcriptomics

                                                5.5.1.5 Pharmacogenomics

                                5.5.2 Imaging technologies         

                                5.5.3 Immunoassays      

                                5.5.4 Cytogenetics          

                                5.5.5 Bioinformatics       

                                5.5.6 IVD multivariate index assays         

                                5.5.7  Y-o-Y Growth Analysis, By Profiling Technologies  

                                5.5.8  Market Attractiveness Analysis, By Profiling Technologies                

                                5.5.9  Market Share Analysis, By Profiling Technologies  

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Disease

                                                6.1.3.3 By Services

                                                6.1.3.4 By Application

                                                6.1.3.5 By Type

                                                6.1.3.6 Profiling Technologies

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Disease

                                                6.1.4.3 By Services

                                                6.1.4.4 By Application

                                                6.1.4.5 By Type

                                                6.1.4.6 Profiling Technologies

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Disease

                                                6.1.5.3 By Services

                                                6.1.5.4 By Application

                                                6.1.5.5 By Type

                                                6.1.5.6 Profiling Technologies

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Abbott Laboratories                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Agendia Bv                 

                8.3 Biocurex Inc                               

                8.4 Biomerieux S.A.                        

                8.5 Biomoda Inc                               

                8.6 Astellas Pharma Us Inc                          

                8.7 Correlogic Systems Inc                           

                8.8 Beckman Coulter Inc                              

                8.9 Becton                          

                8.10 Dickinson And Company                     

                8.11 Clarient Inc                               

                8.12 Diadexus Inc                            

                8.13 Ambrilia Biopharma                              

                8.14 Affymetrix Inc                         

                8.15 Aureon Laboratories Inc.                    

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Cancer Biomarkers Market, By Disease, From 2021 to 2026 (USD Million)
  2. Middle East & Africa Prostate Cancer Market, By Region, From 2021 to 2026 (USD Million)
  3. Middle East & Africa Breast Cancer Market, By Region, From 2021 to 2026 (USD Million)
  4. Middle East & Africa Lung Cancer Market, By Region, From 2021 to 2026 (USD Million)
  5. Middle East & Africa Colorectal Cancer Market, By Region, From 2021 to 2026 (USD Million)
  6. Middle East & Africa Cervical Cancer  Market, By Region, From 2021 to 2026 (USD Million)
  7. Middle East & Africa Other Cancers Market, By Region, From 2021 to 2026 (USD Million)
  8. Middle East & Africa Cancer Biomarkers Market, By Services, From 2021 to 2026 (USD Million)
  9. Middle East & Africa Sample Preparation Market, By Region, From 2021 to 2026 (USD Million)
  10. Middle East & Africa Assay development  Market, By Region, From 2021 to 2026 (USD Million)
  11. Middle East & Africa Biomarkers validation and testing Market, By Region, From 2021 to 2026 (USD Million)
  12. Middle East & Africa Cancer Biomarkers Market, By Application, From 2021 to 2026 (USD Million)
  13. Middle East & Africa Risk Assessment Market, By Region, From 2021 to 2026 (USD Million)
  14. Middle East & Africa Development of molecular diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  15. Middle East & Africa Disease diagnosis Market, By Region, From 2021 to 2026 (USD Million)
  16. Middle East & Africa Drug discovery  Market, By Region, From 2021 to 2026 (USD Million)
  17. Middle East & Africa Development and Drug formulation Market, By Region, From 2021 to 2026 (USD Million)
  18. Middle East & Africa Cancer Biomarkers Market, By Type, From 2021 to 2026 (USD Million)
  19. Middle East & Africa Protein Biomarkers Market, By Region, From 2021 to 2026 (USD Million)
  20. Middle East & Africa Genetic biomarkers  Market, By Region, From 2021 to 2026 (USD Million)
  21. Middle East & Africa Other biomarkers Market, By Region, From 2021 to 2026 (USD Million)
  22. Middle East & Africa Cancer Biomarkers Market, By Profiling Technologies , From 2021 to 2026 (USD Million)
  23. Middle East & Africa Omics technologies  Market, By Region, From 2021 to 2026 (USD Million)
  24. Middle East & Africa Imaging technologies Market, By Region, From 2021 to 2026 (USD Million)
  25. Middle East & Africa Immunoassays Market, By Region, From 2021 to 2026 (USD Million)
  26. Middle East & Africa Cytogenetics Market, By Region, From 2021 to 2026 (USD Million)
  27. Middle East & Africa Bioinformatics Market, By Region, From 2021 to 2026 (USD Million)
  28. Middle East & Africa IVD multivariate index assays Market, By Region, From 2021 to 2026 (USD Million)
  29. Middle East Cancer Biomarkers Market, By Disease, From 2021 to 2026 (USD Million)
  30. Middle East Cancer Biomarkers Market, By Services, From 2021 to 2026 (USD Million)
  31. Middle East Cancer Biomarkers Market, By Application, From 2021 to 2026 (USD Million)
  32. Middle East Cancer Biomarkers Market, By Type, From 2021 to 2026 (USD Million)
  33. Middle East Cancer Biomarkers Market, By Profiling Technologies , From 2021 to 2026 (USD Million)
  34. Africa Cancer Biomarkers Market, By Disease, From 2021 to 2026 (USD Million)
  35. Africa Cancer Biomarkers Market, By Services, From 2021 to 2026 (USD Million)
  36. Africa Cancer Biomarkers Market, By Application, From 2021 to 2026 (USD Million)
  37. Africa Cancer Biomarkers Market, By Type, From 2021 to 2026 (USD Million)
  38. Africa Cancer Biomarkers Market, By Profiling Technologies , From 2021 to 2026 (USD Million)
  39. Middle East & Africa Cancer Biomarkers Market, By Omics technologies , From 2021 to 2026 (USD Million)
  40. Middle East & Africa Genomics Market, By Region, From 2021 to 2026 (USD Million)
  41. Middle East & Africa Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  42. Middle East & Africa Metabolomics Market, By Region, From 2021 to 2026 (USD Million)
  43. Middle East & Africa Transcriptomics Market, By Region, From 2021 to 2026 (USD Million)
  44. Middle East & Africa Pharmacogenomics Market, By Region, From 2021 to 2026 (USD Million)
  45. Middle East Cancer Biomarkers Market, By Omics technologies , From 2021 to 2026 (USD Million)
  46. Africa Cancer Biomarkers Market, By Omics technologies , From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample